Objective: To compare the efficiency of plastic and metal stents for symptomatic pancreatic pseudocyst (PP) drainage and analyze other main associated factors that affect the outcome of drainage therapy. Method: Rates of technical and clinical success, procedure-related side effects (hemorrhage, stent migration, and cyst rupture), reinterventions, and duration of hospital stay. Results: There were 52 patients, 40 patients underwent plastic stent placement and 12 patients underwent lumen-apposing metal stent (LAMS) placement. The total rate of technical success was 100%. The total rate of clinical success was 100%. The total rate of adverse events was 7.7% (4/52). On multiple logistic regression analysis, the use of plastic stents (P < 0.05, Exp B = 12.168) and the presence of a large cyst (P < 0.05, Exp B = 1.036) were shown to significantly increase the risk of reintervention. On multivariate linear regression analysis, etiology of pseudocyst (P < 0.05, B = −8.427, −9.785, −5.514) was associated with prolonged hospital stent, while stent type was not shown be a factor (P > 0.05). Conclusion: Both plastic and LAMSs are proven to be highly efficient in PP drainage. The LAMS is superior in preventing complications such as migration and cyst leakage and reducing the rate of reintervention.
INTRODUCTION
Endoscopic ultrasound (EUS)-guided puncture and drainage is a widely accepted nonsurgical intervention for pancreatic pseudocysts (PPs). [1] [2] [3] Endoscopic inter ventions include endoscopic cystogastrostomy, balloon dilation of the fistula, endoscopic necrosectomy, and placement of double-pigtail stents for drainage. Recently, covered self-expandable metal stents (CSEMS), which have a lumenapposing design and are used to drain fluid collections, have been studied. [4] [5] [6] [7] However, the efficiency of plastic stents and lumen-apposing metal stents (LAMSs) is inconsistent between studies. [8] The aim of this study is to identify whether stent type can affect the clinical outcome and study other risk factors that may also affect the outcome.
PATIENTS AND METHODS
Inclusion criteria for this study are as follows: (1) PP confirmed by CT and EUS; (2) PP presenting with severe symptoms such as abdominal pain, abdominal distension, duodenal obstruction, or biliary obstruction; or (3) asymptomatic patient with PP larger than 5 cm (considered a relative indication for drainage therapy in order to avoid future serious complications, such as disruption or infection). Exclusion criteria were (1) walled-off pancreatic necrosis; (2) thin, irregular pseudocyst wall; (3) coagulopathy; or (4) unconfirmed diagnosis. All patients provided informed consent for the procedure. Complete blood counts, prothrombin time, and partial thromboplastin time were normal for all patients.
Main outcome measurement
Technical success is defined as accomplishment of stent placement. Clinical success is the resolution of clinical symptoms in combination with a decrease in the size of the PPs to 3 cm on imaging (mainly EUS or CT) within 3 months. Procedure-related side effects included hemorrhage, stent migration into the cyst, cyst rupture with the use of cystotome, and severe infection. Reinterventions are endoscopic treatments performed after the initial EUSguided stent placement. Failures include residual clinical symptoms, cyst reduction less than 50% in 3 months, or altered to open surgery. Hospital stay is calculated from the day of the initial EUS-guided drainage in hospital to the day of discharge.
Devices
Longitudinal echoendoscope (PENTAXEG3830UT, Pentax Corporation, Japan) with a working channel of 3.8 mm accessible to a 10 Fr stent was used. Echo-Tip Ultra needle (19-G, Wilson-Cook Medic, USA) with a lumen of 0.8 mm in diameter was fitted to a 0.035-inch guidewire (Tracer metro direct wire guide, 0.035 inch/480 mm, Wilson Cook Medical Inc, USA). Cystotome (10-Fr, Wilson-Cook Medic) was used to dilate the tract and create a large fistula. A nasobiliary drainage catheter (7-Fr, WilsonCook Medic) was used for drainage of the peritoneum or infected cyst. A double-pigtail stent (10 Fr, Endo-Flex GmbH, Germany) facilitated the drainage of the cyst.
EUS-guided drainage process with plastic stent
The echoendoscope was introduced to scan the abdominal cavity for the pseudocyst and mark the puncture point. The contact zone (i.e., the closest approximation of the region between the gastric wall and cyst wall) was identified. Color Doppler was applied to identify the interposing vessels and thus avoid them during puncture. An EchoTip Ultra endoscopic needle was then introduced via the working channel of the echoendoscope, and the cyst was punctured under EUS guidance. A sample of the cyst was aspirated for biochemical, cytological, and tumor marker analysis. If the cyst was very small, this sample was limited to avoid rapid cyst deflation, which can cause increased difficulty during stent placement. The guidewire was inserted through the needle lumen into the cyst and coiled into 2-3 loops, and the needle was removed. The needle path was then dilated by the cystotome and a balloon dilator. A double-pigtail stent (10 Fr) was then introduced for drainage (Figure 1 ).
EUS-guided drainage process with metal stent
The initial steps were the same as the plastic stent placement. After the needle path was dilated by the cystotome, the stent (10 mm/35 mm; Micro-Tech/Nan Jing CO., Ltd.) was slowly deployed into the cyst under the guidance of EUS until the distal flared end was completely open (Figure 2 ). Gentle traction was applied to pull the cyst wall close to the gastric wall. Then, under endoscopic surveillance, the remainder of the stent was deployed, keeping the proximal end in sight. The stomach was irrigated with saline, and EUS scanning was used to confirm the position of the stent and rule out further leakage. In some cases, a doublepigtail stent (PE double-pigtail 10 Fr/7 cm, 10 Fr/3 cm or 10 Fr/5 cm, ENDO-FLEX GmbH, Germany) was introduced through the metal stent for auxiliary drainage.
Statistical analysis
Categorical variables were studied as percentage. Continuous variables were studied as mean with standard deviations. Independent variables used in the models included gender, age, etiology, size in EUS, and type of stents. Outcomes included reintervention and hospital days. Multivariate linear regression analysis was used to assess the relationship between clinical factors and hospital stay. The absolute value of B was used to predict the correlation. Logistic regression was used to test for effect associations among reintervention and independent variables. Absolute value of Exp B was used to predict the correlation. All reported P values of <0.05 were considered to indicate statistical significance. Statistical analysis was performed using SPSS 21.0 software.
RESULTS
Fifty-two patients were enrolled in this study. The main characteristics of these patients are listed in Table 1 . Metal or plastic stents were achieved in 52/52 (100%) of the patients. Massive hemorrhage was observed in two patients during stent placement and was self-limited after the drainage was complete. Plastic stent migration into the cyst was found in one patient 2 weeks after drainage when the patient started to complain of obvious abdominal distention. Migration of the stent into the cyst was detected by CT. In order to retrieve the stent, a new fistula was created under EUS guidance. A regular endoscope was advanced into the cyst, and the stent was retrieved with foreign body forceps. Unfortunately, a devastating cyst hemorrhage occurred during retrieval of the stent. The hemorrhage was stopped using interventional vascular embolization. One patient with a plastic stent experienced leakage of a large amount of cyst fluid into the abdominal cavity after the procedure (Figure 3 ). The main complaints were abdominal pain and fever. The leakage and symptoms resolved following EUS-guided abdominal drainage with endoscopic nasobiliary drainage (ENBD). Clinical resolution occurred in all 52 (100%) patients in this study ( Table 2) . On multiple logistic regression analysis, stent type was associated with risk of reintervention (P < 0.05). Other factors such as cyst size and age were also found to be related. According to the B value, the use of a plastic stent increases the risk of reintervention. Another main factor for reintervention is cyst size. On multivariate linear regressions analysis, stent type was not related to the duration of hospital stay (P > 0.05). Among the associated factors, etiology of the pseudocyst showed most correlation with the length of hospital stay (Table 3) . 
DISCUSSION
PPs develop secondary to fluid leakage or liquefaction from pancreatic necrosis after acute pancreatitis, chronic pancreatitis, surgery, or trauma. [9] [10] [11] [12] EUS has been accepted as an important tool in pancreas disease evaluation [13] [14] [15] and EUS-guided transluminal treatment of PPs is an effective alternative to surgical treatment. [16] [17] [18] [19] [20] [21] [22] [23] A CSEMS is primarily used if the contents of the collection are thick, necrotic, or infected, as these collections may not adequately drain through plastic stents. [24] [25] [26] Recently, CSEMSs have come to be used in all kinds of PPs. CSEMSs have an advantage in that only a single stent may be required rather than multiple plastic stents. The self-expandable stent can occlude the tract between the stomach and the cyst, which may decrease the leakage from the cyst. Moreover, they provide a larger diameter compared to plastic stents. Therefore, they decrease the risk of occlusion and so might reduce the need for repeated procedures. In addition, the anastomosis created by a metal stent can facilitate the necrosectomy procedure within the cyst. Our study used the newly designed, LAMS, which has a dog-bone-like shape. These stents are also fully covered, with two large flare ends and a short waist. This kind of stent imparts lumen-to-lumen anchorage. In the meantime, other newly developed LAMSs has been applied in clinic as well. [6, 7, [27] [28] [29] Technically, this design may be effective in anastomosis, even between two lumens that are physically separated. [30] There has not been strong evidence thus far in the published literature that favors the lumen-apposing stent when compared with the plastic stent in resolving simple PPs. The choice of CESMs has continued to depend on the endoscopists' personal choice rather than evidenced-based findings.
EUS-guided PP drainage had a high technical success rate with either metal or plastic stents in our study. This result consistently matches reports from other centers (77-100%). [31] [32] [33] [34] As the CSEMs are shorter in length, the release of these stents should be more precise. Excess pushing of the stents will cause immediate migration. In our study, the whole process was performed by one skilled endosonographer under the surveillance of EUS imaging without fluoroscopic guidance. [21, 35] Both metal and plastic stents can be clearly visualized by EUS.
Migration is a common complication of drainage therapy [36] [37] [38] [39] There are two directions of migration, inside and outside the pseudocyst. Early migration outside the cyst will cause incomplete drainage and may need reintervention. Most migrations that occurred in our study happened in the late stage when the cyst had successfully resolved. This kind of migration cannot be considered to be a side effect. Migration of the stent inside the cyst is a more curious side effect and may need further intervention. In our study, stent migration into the cyst occurred in a patient with double-pigtail plastic stents. On the other hand, even in the published articles, there have been no cases of migration of lumen-apposing stents. [40, 41] As a result, although the statistics has not yet been proven, it appears that the newly developed lumen-apposing stents are antimigratory.
Bleeding is another side effect that may occur in drainage therapy. [42] Large pseudocysts are often accompanied by portal vein hypertension and transmural varicose veins. Hemorrhage may occur in the creation of a fistula, but the hemorrhage becomes self-limited as soon as the stents are released. It has been reported that delayed hemorrhage may occur because of inner cyst wall injury by stents. Gastric or duodenal ulcers may occur a few days after placement because of friction from the end of the metal stents. Thus far, there has been only one reported case of bleeding associated with metal stents. [43] [44] [45] In our experience, silicone plastic stents or metal stents with blunt ends would be effective in reducing the risk of bleeding caused by cystic or gastric wall injury. In the other studies, metal stents were effectively applied for the needle path bleeding caused by dilation. [46] The clinical success rate was very high in our study. PPs can be resolved by both metal and plastic stents after 3 months of drainage. A systematic review by Bang et al. [47] concluded that there was no difference in overall treatment success between patients treated with plastic stents versus metal stents (81% [95% CI, 77-84%] vs. 82% [95% CI, 74-88%]). There was also no difference in the rate of recurrence between plastic and metal stents. Evidence from this analysis does not support the routine placement of metal over plastic stents for transmural drainage of PPs or even walled-off pancreatic necrosis. In our study, we further revealed that these two types of stents differ in the recovery process after the initial endoscopic procedure. Metal stents are superior in reducing the risk of reintervention after the initial endoscopic procedure. The reintervention that occurred in the plastic stents group were all within a few days after the initial procedure and were mainly due to secondary infection of the cyst or a large leak of cyst fluid, resulting in infective ascites after the stent placement. However, timely reinterventions, including establishing a drainage path via redilation and EUS-guided abdominal cavity drainage via ENBD, were effective in resolving the infection and did not lead to extension of hospital stay. [48] As a result, stent type in our study was not associated with the length of hospital stay post-procedure.
In this study, we also found that there are two factors, diameter and etiology of the cyst, that may significantly affect the outcome. Diameter is an important factor that was found to be closely associated with both hospital days and reintervention. It seems that larger cysts have a greater risk of becoming infected after the initial drainage and cannot be effectively resolved following one-time endoscopic management; repeat endoscopic interventions are usually needed. [49] Some of these repeat interventions may extend the hospital stay. This associated factor has been seldom discussed in previously published articles. Another factor strongly associated with hospital days and reintervention that has not been studied before is the etiology of the pseudocysts. According to the data, patients with posttraumatic PPs may have the longest hospital stay, and after surgery patients with PP may have the shortest recovery time after drainage.
Limitations
This is a retrospective study with a limited number of patients. Cost analysis was not considered in this study. Metal stents are much more expensive than plastic ones; however, reinterventions after plastic stent placement may also increase the cost. Further studies should address these issues.
CONCLUSION
In our study, both plastic and LAMSs were proven to be highly effective in PP drainage. The LAMS is superior in preventing complications such as migration and cyst leakage as well as reducing reintervention after the initial endoscopic drainage. Furthermore, diameter of the PPs is an important factor associated with the main outcome (large cysts often need more endoscopic interventions and prolong the hospital stay in some cases). Posttraumatic PPs require more recovery time after EUS-guided drainage.
